医药行业日报:默沙东WINREVAIR三期临床成功

太平洋证券股份...
02 Apr

报告摘要市场表现:2025 年4 月1 日,医药板块涨跌幅+3.34%,跑赢沪深300 指数3.33pct,涨跌幅居申万31 个子行业第1 名。各医药子行业中,其他生物制品(+3.95%)、体外诊断(+3.63%)、疫苗(+3.60%)表现居前,医院(+1.19%)、医疗设备(+2.27%)、医药流通(+2.26%)表现居后。个股方面,日涨幅榜前3 位分别为陇神戎发(+20.05%)、多瑞医药(+...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10